Biotechnology company developing gene therapies and regenerative medicine for heart disease.
About
Tenaya Therapeutics is a clinical-stage biotechnology company dedicated to discovering, designing, developing, and delivering potentially curative gene therapies for heart disease. Their lead programs, TN-201 and TN-401, target MYBPC3-associated hypertrophic cardiomyopathy (HCM) and PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), respectively. They aim to address the underlying drivers of these debilitating conditions to improve and extend the lives of patients and their families.
Tags
Total Employees
99
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Tenaya Therapeutics do?
Tenaya Therapeutics is a clinical-stage biotechnology company dedicated to discovering, designing, developing, and delivering potentially curative gene therapies for heart disease. Their lead programs, TN-201 and TN-401, target MYBPC3-associated hypertrophic cardiomyopathy (HCM) and PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), respectively. They aim to address the underlying drivers of these debilitating conditions to improve and extend the lives of patients and their…
How much funding has Tenaya Therapeutics raised?
Tenaya Therapeutics has raised a total of $159M in funding. The most recent round on record is Public Offering.
Where is Tenaya Therapeutics headquartered?
Tenaya Therapeutics is headquartered in South San Francisco, United States.
When was Tenaya Therapeutics founded?
Tenaya Therapeutics was founded in 2016.
What industry does Tenaya Therapeutics operate in?
Tenaya Therapeutics operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.
How many employees does Tenaya Therapeutics have?
Tenaya Therapeutics has approximately 99 people on record.
Similar Startups